Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating) was the target of a significant decline in short interest in the month of May. As of May 31st, there was short interest totalling 1,540,000 shares, a decline of 24.5% from the May 15th total of 2,040,000 shares. Based on an average trading volume of 374,900 shares, the […]
Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating)’s stock price dropped 5.1% during trading on Friday . The company traded as low as $3.76 and last traded at $3.76. Approximately 163,080 shares were traded during trading, a decline of 41% from the average daily volume of 274,287 shares. The stock had previously closed at $3.96. Wall […]
Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating) – Analysts at Cantor Fitzgerald decreased their FY2023 earnings per share estimates for shares of Ocuphire Pharma in a report issued on Tuesday, May 16th. Cantor Fitzgerald analyst K. Kluska now expects that the company will post earnings of ($0.69) per share for the year, down from their […]
Lincoln National Corp purchased a new position in shares of Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 11,600 shares of the company’s stock, valued at approximately $41,000. Lincoln National Corp […]
Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating) was the recipient of a significant drop in short interest in March. As of March 31st, there was short interest totalling 675,000 shares, a drop of 25.5% from the March 15th total of 906,400 shares. Based on an average daily volume of 161,500 shares, the days-to-cover ratio is […]